Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Scienture Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$7.46 |
52 Week High | US$13.42 |
52 Week Low | US$6.29 |
Beta | 0 |
11 Month Change | -5.57% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -37.26% |
Recent News & Updates
Recent updates
Shareholder Returns
SCNX | US Healthcare Services | US Market | |
---|---|---|---|
7D | -1.7% | -0.9% | 0.9% |
1Y | n/a | 0.6% | 32.3% |
Return vs Industry: Insufficient data to determine how SCNX performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how SCNX performed against the US Market.
Price Volatility
SCNX volatility | |
---|---|
SCNX Average Weekly Movement | 15.2% |
Healthcare Services Industry Average Movement | 9.0% |
Market Average Movement | 6.4% |
10% most volatile stocks in US Market | 14.8% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: SCNX's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SCNX's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Suren Ajjarapu | scienture.com |
Scienture Holdings, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics, and independent pharmacies. Scienture Holdings, Inc. is headquartered in Tampa, Florida.
Scienture Holdings, Inc. Fundamentals Summary
SCNX fundamental statistics | |
---|---|
Market cap | US$10.88m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs SCNX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SCNX income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did SCNX perform over the long term?
See historical performance and comparison